Literature DB >> 15758016

Chemotherapy for brain tumors--a new beginning.

Lisa M DeAngelis.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15758016     DOI： 10.1056/NEJMe058010

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  30 in total

1.  Magnetically-enabled and MR-monitored selective brain tumor protein delivery in rats via magnetic nanocarriers.

Authors:  Beata Chertok; Allan E David; Victor C Yang
Journal:  Biomaterials       Date:  2011-05-31       Impact factor: 12.479

2.  Novel cell lines established from pediatric brain tumors.

Authors:  Jingying Xu; Anat Erdreich-Epstein; Ignacio Gonzalez-Gomez; Elizabeth Y Melendez; Goar Smbatyan; Rex A Moats; Michael Rosol; Jaclyn A Biegel; C Patrick Reynolds
Journal:  J Neurooncol       Date:  2011-11-27       Impact factor: 4.130

3.  An update on the first decade of the European centralized procedure: how many innovative drugs?

Authors:  Domenico Motola; Fabrizio De Ponti; Elisabetta Poluzzi; Nello Martini; Pasqualino Rossi; Maria Chiara Silvani; Alberto Vaccheri; Nicola Montanaro
Journal:  Br J Clin Pharmacol       Date:  2006-06-23       Impact factor: 4.335

4.  Targeted inhibition of cyclic AMP phosphodiesterase-4 promotes brain tumor regression.

Authors:  Patricia Goldhoff; Nicole M Warrington; David D Limbrick; Andrew Hope; B Mark Woerner; Erin Jackson; Arie Perry; David Piwnica-Worms; Joshua B Rubin
Journal:  Clin Cancer Res       Date:  2008-12-01       Impact factor: 12.531

5.  Should we reoperate for recurrent high-grade astrocytoma?

Authors:  Jin-fang Xu; Jun Fang; Yi Shen; Jian-min Zhang; Wei-guo Liu; Hong Shen
Journal:  J Neurooncol       Date:  2011-05-17       Impact factor: 4.130

6.  STAT3 Blockade Inhibits Radiation-Induced Malignant Progression in Glioma.

Authors:  Jasmine Lau; Shirin Ilkhanizadeh; Susan Wang; Yekaterina A Miroshnikova; Nicolas A Salvatierra; Robyn A Wong; Christin Schmidt; Valerie M Weaver; William A Weiss; Anders I Persson
Journal:  Cancer Res       Date:  2015-08-17       Impact factor: 12.701

7.  Temozolomide chemotherapy in patients with recurrent malignant gliomas.

Authors:  Seung-Ho Yang; Moon-Kyu Kim; Tae-Kyu Lee; Kwan-Sung Lee; Sin-Soo Jeun; Chun-Kun Park; Joon-Ki Kang; Moon-Chan Kim; Yong-Kil Hong
Journal:  J Korean Med Sci       Date:  2006-08       Impact factor: 2.153

8.  Improved killing of human high-grade glioma cells by combining ionizing radiation with oncolytic parvovirus H-1 infection.

Authors:  Karsten Geletneky; Andreas D Hartkopf; Robert Krempien; Jean Rommelaere; Joerg R Schlehofer
Journal:  J Biomed Biotechnol       Date:  2010-03-07

9.  REV3L confers chemoresistance to cisplatin in human gliomas: the potential of its RNAi for synergistic therapy.

Authors:  Huibo Wang; Shu-Yu Zhang; Shuai Wang; Juan Lu; Wenting Wu; Lin Weng; Dan Chen; Yu Zhang; Zhipeng Lu; Jingmin Yang; Yuanyuan Chen; Xu Zhang; Xiaofeng Chen; Caihua Xi; Daru Lu; Shiguang Zhao
Journal:  Neuro Oncol       Date:  2009-12       Impact factor: 12.300

10.  Treatment Patterns, Survival, and Healthcare Costs of Patients with Malignant Gliomas in a Large US Commercially Insured Population.

Authors:  Saurabh Ray; Machaon M Bonafede; Nimish A Mohile
Journal:  Am Health Drug Benefits       Date:  2014-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.